AEGiS-PRn: Medical Services Increases Presence in Middle East with Approvals in Lebanon

Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.

Medical Services Increases Presence in Middle East with Approvals in Lebanon

PRNewswire - December 13, 2005

EDMONTON, Alberta, Dec. 13 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC: MSITF) is pleased to announce that it has received regulatory approval to sell its VScan HIV 1&2 test kits in Lebanon. The distributor for Lebanon has already placed an order for in excess of 100,000 VScan HIV test kits as a result of this approval. While the original order only generates in excess of US$250,000.00, Medical Services has been assured that there are orders for greater than 750,000 VScan HIV test kits currently being negotiated. The kits ordered and being negotiated for are for delivery in 2006. There has also been significant interest in the VScan TB and Hepatitis test kits. The distributor in Lebanon estimates that the market for the VScan TB test kit will be approximately 400,000 test kits per year and in excess of 500,000 per year for the VScan Hepatitis test kit.

The Company wishes to report that it is making significant progress on the audited statements and is moving as fast as possible to get them completed.

About VScan

The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or media contact Bill Whitehead at (416) 822 5883 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com .

NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.

SOURCE Medical Services International Inc.

Web Site: http://www.medicalservicesintl.com

http://www.minerva-biotech.com

051213
PR051219

Copyright © 2005 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .